keyword
https://read.qxmd.com/read/38702973/a-multicenter-open-label-single-arm-trial-of-the-long-term-safety-of-empagliflozin-treatment-for-refractory-diabetes-mellitus-with-insulin-resistance-empire-02
#1
JOURNAL ARTICLE
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
AIMS/INTRODUCTION: Insulin resistance syndrome and lipoatrophic diabetes are rare conditions characterized by the development of treatment-refractory diabetes with severe insulin resistance. We recently conducted a 24 week, multicenter, single-arm trial (EMPIRE-01) that demonstrated a certain level of effectiveness and safety of empagliflozin for these conditions. To evaluate treatment safety over a longer period, we have now performed an additional 28 week trial (EMPIRE-02) that followed on from EMPIRE-01...
May 4, 2024: Journal of Diabetes Investigation
https://read.qxmd.com/read/38702735/association-of-non-insulin-based-insulin-resistance-indices-with-disease-severity-and-adverse-outcome-in-idiopathic-pulmonary-arterial-hypertension-a-multi-center-cohort-study
#2
MULTICENTER STUDY
Sicheng Zhang, Luyang Gao, Sicong Li, Manqing Luo, Lichuan Chen, Qunying Xi, Zhihui Zhao, Qing Zhao, Tao Yang, Qixian Zeng, Xin Li, Zhihua Huang, Anqi Duan, Yijia Wang, Qin Luo, Yansong Guo, Zhihong Liu
BACKGROUND: Insulin resistance (IR) plays an important role in the pathophysiology of cardiovascular disease. Recent studies have shown that diabetes mellitus and impaired lipid metabolism are associated with the severity and prognosis of idiopathic pulmonary arterial hypertension (IPAH). However, the relationship between IR and pulmonary hypertension is poorly understood. This study explored the association between four IR indices and IPAH using data from a multicenter cohort. METHODS: A total of 602 consecutive participants with IPAH were included in this study between January 2015 and December 2022...
May 3, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38702680/insulin-sensitivity-estimates-and-their-longitudinal-association-with-coronary-artery-disease-in-type-1-diabetes-does-it-matter
#3
COMPARATIVE STUDY
Stefan Mutter, Erika B Parente, Andrzej S Januszewski, Johan R Simonsen, Valma Harjutsalo, Per-Henrik Groop, Alicia J Jenkins, Lena M Thorn
BACKGROUND: Insulin resistance and chronic kidney disease are both associated with increased coronary artery disease risk. Many formulae estimating glucose disposal rate in type 1 diabetes infer insulin sensitivity from clinical data. We compare associations and performance relative to traditional risk factors and kidney disease severity between three formulae estimating the glucose disposal rate and coronary artery disease in people with type 1 diabetes. METHODS: The baseline glucose disposal rate was estimated by three (Williams, Duca, and Januszewski) formulae in FinnDiane Study participants and related to subsequent incidence of coronary artery disease, by baseline kidney status...
May 3, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38702615/the-association-between-the-triglyceride-glucose-index-and-in-stent-restenosis-in-patients-undergoing-percutaneous-coronary-intervention-a-systematic-review-and-meta-analysis
#4
JOURNAL ARTICLE
Haodong Jiang, Yuntong Liu, Haoyu Guo, Zhihao Liu, Zhibo Li
BACKGROUND: Insulin resistance (IR) can lead to cellular metabolic disorders, activation of oxidative stress, and endothelial dysfunction, contributing to in-stent restenosis (ISR). The triglyceride-glucose index (TyG index), a new indicator reflecting IR, is extensively researched in the cardiovascular field. This study, through a meta-analysis, aimed to utilize a larger combined sample size and thereby enhance the overall test efficacy to explore the TyG index-ISR relationship. METHODS: A thorough search was conducted in the PubMed, EMBASE, Web of Science, and Cochrane Library databases to find original papers and their references published between 1990 and January 2024...
May 3, 2024: BMC Cardiovascular Disorders
https://read.qxmd.com/read/38701970/metformin-as-adjuvant-treatment-in-hepatitis-c-virus-infections-and-associated-complications
#5
REVIEW
Dylan Landis, Alex Sutter, Sachi Khemka, Busara Songtanin, Jacob Nichols, Kenneth Nugent
Hepatitis C virus is an important global cause of hepatitis and subsequently cirrhosis and hepatocellular carcinoma. These infections may also cause extrahepatic manifestations, including insulin resistance and type 2 diabetes mellitus. These two complications can potentially reduce sustained virologic responses (SVR) in some drug regimens for this infection. Metformin has important biochemical effects that can limit viral replication in cellular cultures and can improve the response to antiviral drug therapy based on ribavirin and interferon...
May 1, 2024: American Journal of the Medical Sciences
https://read.qxmd.com/read/38701709/identification-of-factors-associated-with-sarcopenic-obesity-development-literature-review-and-expert-panel-voting
#6
REVIEW
A Pinel, C Guillet, F Capel, M Pouget, M De Antonio, B Pereira, E Topinkova, D Eglseer, R Barazzoni, A J Cruz-Jentoft, J D Schoufour, P J M Weijs, Y Boirie
Sarcopenic obesity (SO) is defined as the combination of excess fat mass (obesity) and low skeletal muscle mass and function (sarcopenia). The identification and classification of factors related to SO would favor better prevention and diagnosis. The present article aimed to (i) define a list of factors related with SO based on literature analysis, (ii) identify clinical conditions linked with SO development from literature search and (iii) evaluate their relevance and the potential research gaps by consulting an expert panel...
April 24, 2024: Clinical Nutrition
https://read.qxmd.com/read/38701557/gpr30-selective-agonist-g-1-induced-insulin-resistance-in-ovariectomized-mice-on-high-fat-diet-and-its-mechanism
#7
JOURNAL ARTICLE
Congcong Lu, Da Liu, Min Li, Xiaocui Shi, Jingyue Guan, Guoyuan Song, Yajuan Yin, Mingqi Zheng, Fangfang Ma, Gang Liu
BACKGROUND: Previous in vivo and in vitro studies have demonstrated that estrogen receptor agonist G-1 regulates glucose and lipid metabolism. This study focused on the effects of G-1 on cardiometabolic syndrome and anti-obesity under a high fat diet (HFD). METHODS: Bilateral ovariectomized female mice were fed an HFD for 6 weeks, and treated them with G-1. A cardiomyocyte insulin resistance model was used to simulate the in vivo environment. The main outcome measures were blood glucose, body weight, and serum insulin levels to assess insulin resistance, while cardiac function and degree of fibrosis were assessed by cardiac ultrasound and pathological observations...
April 27, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38701355/comprehensive-clinical-and-genetic-analyses-of-circulating-bile-acids-and-their-associations-with-diabetes-and-its-indices
#8
JOURNAL ARTICLE
Ibrahim Choucair, Deepthi P Mallela, James R Hilser, Jaana A Hartiala, Ina Nemet, Valentin Gogonea, Lin Li, Aldons J Lusis, Michael A Fischbach, W H Wilson Tang, Hooman Allayee, Stanley L Hazen
Bile acids (BAs) are cholesterol-derived compounds that regulate glucose, lipid, and energy metabolism. Despite their significance in glucose homeostasis, the association between specific BA molecular species and their synthetic pathways with diabetes mellitus (DM) is unclear. Here, we used a recently validated stable-isotope dilution highperformance liquid chromatography with tandem mass spectrometry (LC-MS/MS) method to quantify a panel of BAs in fasting plasma from subjects (n=2,145) and explored structural and genetic determinants of BAs linked to DM, insulin resistance and obesity...
May 3, 2024: Diabetes
https://read.qxmd.com/read/38701139/the-associations-between-serum-insulin-like-growth-factor-i-brain-white-matter-volumes-and-cognition-in-mild-cognitive-impairment-and-alzheimer-s-disease
#9
JOURNAL ARTICLE
Alexandra Horvath, Patrick Quinlan, Carl Eckerström, N David Åberg, Anders Wallin, Johan Svensson
BACKGROUND: Insulin-like growth factor-I (IGF-I) regulates myelin, but little is known whether IGF-I associates with white matter functions in subjective and objective mild cognitive impairment (SCI/MCI) or Alzheimer's disease (AD). OBJECTIVE: To explore whether serum IGF-I is associated with magnetic resonance imaging - estimated brain white matter volumes or cognitive functions. METHODS: In a prospective study of SCI/MCI (n = 106) and AD (n = 59), we evaluated the volumes of the total white matter, corpus callosum (CC), and white matter hyperintensities (WMHs) as well as Mini-Mental State Examination (MMSE), Trail Making Test A and B (TMT-A/B), and Stroop tests I-III at baseline, and after 2 years...
April 27, 2024: Journal of Alzheimer's Disease: JAD
https://read.qxmd.com/read/38701096/semaglutide-combined-with-empagliflozin-vs-monotherapy-for-non-alcoholic-fatty-liver-disease-in-type-2-diabetes-study-protocol-for-a-randomized-clinical-trial
#10
RANDOMIZED CONTROLLED TRIAL
Yu-Hao Lin, Zhi-Jun Zhang, Jin-Qing Zhong, Zhi-Yi Wang, Yi-Ting Peng, Yan-Mei Lin, Huo-Ping Zhang, Jian-Qing Tian
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is strongly associated with type 2 diabetes mellitus (T2DM). Lifestyle intervention remains a preferred treatment modality for NAFLD. The glucagon-like peptide (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors have been developed as new glucose-lowering drugs, which can improve fatty liver via an insulin-independent glucose-lowering effect. However, studies exploring the efficacy of GLP-1 receptor agonists combined with SGLT-2 inhibitors in patients with NAFLD and T2DM are scanty...
2024: PloS One
https://read.qxmd.com/read/38701059/oral-glucose-tolerance-test-clearance-in-type-2-diabetes-patients-who-underwent-remission-following-intense-lifestyle-modification-a-quasi-experimental-study
#11
JOURNAL ARTICLE
Pramod Tripathi, Nidhi Kadam, Diptika Tiwari, Anagha Vyawahare, Baby Sharma, Thejas Kathrikolly, Maheshkumar Kuppusamy, Venugopal Vijayakumar
Achieving diabetes remission (HbA1c<48mmol/mol without the use of anti-diabetic medication for 3 months) might not assure restoration of a normal glycemic profile [fasting blood sugar level <5.6 mmol/L and Post-Prandial (PP) blood glucose <7.8mmol/L]. The study investigates the factors associated with OGTT clearance in patients under type 2 diabetes remission. Four hundred participants who achieved remission during a one-year online structured lifestyle modification program, which included a plant-based diet, physical activity, psychological support, and medical management (between January 2021 and June 2022), and appeared for the OGTT were included in the study...
2024: PloS One
https://read.qxmd.com/read/38700793/metabolic-dysfunction-associated-steatotic-liver-disease-and-atherosclerosis
#12
REVIEW
Yulino Castillo-Núñez, Paloma Almeda-Valdes, Guillermo González-Gálvez, María Del Rosario Arechavaleta-Granell
PURPOSE OF REVIEW: To update information about the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and atherosclerosis. This review emphasizes the potential mechanisms linking MASLD with atherosclerosis and the possible causal relationships between these conditions. RECENT FINDINGS: An increased risk of cardiovascular disease is related to MASLD. Several molecular, cellular, and metabolic mechanisms have been described to explain the development of atherothrombosis in MASLD patients...
May 3, 2024: Current Diabetes Reports
https://read.qxmd.com/read/38700145/the-impact-of-systemic-administration-of-polyphenols-on-periodontitis-associated-with-diabetes-mellitus-a-systematic-review
#13
JOURNAL ARTICLE
Kornelija Rogalnikovaite, Auste Antipoviene, Asta Burbulyte, Egle Aida Bendoraitiene
OBJECTIVE: The aim of this work was to explore the potential of polyphenol supplement consumption in enhancing the treatment of periodontitis and diabetes mellitus in both diabetic animals and humans. MATERIALS AND METHODS: A comprehensive search across eight databases (MEDLINE, EBSCO, Taylor & Francis, PRIMO, Web of Science, Wiley Online Library, ScienceDirect, and SAGE Journals) and two registers (ClinicalTrials.gov and Cochrane Library Trials) was conducted...
May 3, 2024: Acta Odontologica Scandinavica
https://read.qxmd.com/read/38699692/clinical-observation-of-laparoscopic-sleeve-gastrectomy-and-metformin-treatment-in-obese-pcos-patients
#14
JOURNAL ARTICLE
Qingya Ma, Xiaojing He, Zijie Fu, Xiaodong Ren, Ranran Sun, Siqi Zhu, Yahui Bian, Xiaodong Li
BACKGROUND: To observe the basic metabolic characteristics of obese patients with polycystic ovarian syndrome (PCOS), and observe and compare the effect of laparoscopic sleeve gastrectomy and metformin treatment after 3 months. METHODS: In January to December 2018, the Second Hospital of Hebei Medical University selected 104 women who were classified as obese with a body mass index (BMI) of 28 kg/cm2 or higher and had PCOS. They were divided into obese PCOS group (53 cases) and obese non-PCOS group (51 cases)...
April 23, 2024: Journal of Medical Biochemistry
https://read.qxmd.com/read/38699515/adipokine-adiponectin-rs1501299-gene-variant-and-patient-characteristics-in-relation-to-metabolic-associated-fatty-liver-disease
#15
JOURNAL ARTICLE
Amal A Mohamed, Soha Hassanin, Ahmed A Mohamed, Dalia Zaafar, Rasha Mohamed, Mohamed B Hassan, Al-Shaymaa A Hassanin, Eman Alsayed Abouahmad, Mohamed A Sakr, Soha M Abd El Salam, Reem A M Abdelghafour, Nashwa M Muharram, Marwa K Darwish, Saadia Faried, Karmia Nasraldin, Wael Hafez
BACKGROUND: Several genetic and metabolic variables, most notably the variation in the adipokine gene rs1501298, have been linked to metabolic-associated fatty liver disease etiopathogenesis (MAFLD). Liver biopsy, the gold standard for diagnosing MAFLD, is an invasive procedure; therefore, alternative diagnostic methods are required. Consequently, the integration of these metabolic variables with some of the patients' characteristics may facilitate the development of noninvasive diagnostic methods that aid in the early detection of MAFLD, identification of at-risk individuals and planning of management strategies...
2024: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/38698772/risk-factors-and-metabolomics-of-mild-cognitive-impairment-in-type-2-diabetes-mellitus
#16
JOURNAL ARTICLE
Tao Luo, Xiao Jiang, Ning Xu, Xinyu Zhao, Xingjie Xie, Xiuwen Xia, XiaoLong Bian, Haixia Liu
Objective: This study aimed to explore the risk factors, metabolic characteristics, and potential biomarkers of mild cognitive impairment in type 2 diabetes mellitus (T2DM-MCI) and to provide potential evidence for the diagnosis, prevention, and treatment of mild cognitive impairment (MCI) in patients with type 2 diabetes mellitus (T2DM). Methods: A total of 103 patients with T2DM were recruited from the Endocrinology Department of The Second Affiliated Hospital of Dalian Medical University for inclusion in the study...
2024: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/38698462/ficolin-3-promotes-ferroptosis-in-hcc-by-downregulating-ir-srebp-axis-mediated-mufa-synthesis
#17
JOURNAL ARTICLE
Yanmei Yuan, Junting Xu, Quanxin Jiang, Chuanxin Yang, Ning Wang, Xiaolong Liu, Hai-Long Piao, Sijia Lu, Xianjing Zhang, Liu Han, Zhiyan Liu, Jiabin Cai, Fang Liu, Suzhen Chen, Junli Liu
BACKGROUND: Targeting ferroptosis has been identified as a promising approach for the development of cancer therapies. Monounsaturated fatty acid (MUFA) is a type of lipid that plays a crucial role in inhibiting ferroptosis. Ficolin 3 (FCN3) is a component of the complement system, serving as a recognition molecule against pathogens in the lectin pathway. Recent studies have reported that FCN3 demonstrates inhibitory effects on the progression of certain tumors. However, whether FCN3 can modulate lipid metabolism and ferroptosis remains largely unknown...
May 3, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38698251/the-role-of-exosome-derived-mirnas-in-inter-cell-crosstalk-among-insulin-related-organs-in-type-2-diabetes-mellitus
#18
REVIEW
Ting Lu, Ying Zheng, Xiaoling Chen, Zhiyong Lin, Chaoqi Liu, Chengfu Yuan
Exosomes are small extracellular vesicles secreted by almost all cell types, and carry diverse cargo including RNA, and other substances. Recent studies have focused exosomal microRNAs (miRNAs) on various human diseases, including type 2 diabetes mellitus (T2DM) and metabolic syndrome (METS) which accompany the occurrence of insulin resistance. The regulation of insulin signaling has connected with some miRNA expression which play a significant regulatory character in insulin targeted cells or organs, such as fat, muscle, and liver...
May 3, 2024: Journal of Physiology and Biochemistry
https://read.qxmd.com/read/38697949/creb3-mediates-the-transcriptional-regulation-of-pgc-1%C3%AE-a-master-regulator-of-energy-homeostasis-and-mitochondrial-biogenesis
#19
JOURNAL ARTICLE
Briana Locke, Elena Campbell, Ray Lu
Lipid metabolism hinges on a balance between lipogenesis and fatty acid oxidation (FAO). Disruptions in this balance can induce endoplasmic reticulum (ER) stress triggering the unfolded protein response (UPR) and contribute to metabolic diseases. The UPR protein, Luman or CREB3, has recently been implicated in metabolic regulation-CREB3 knockout mice exhibit resistance to diet-induced obesity and altered insulin sensitivity. Here, we show that CREB3 activated PPARGC1A transcription from a 1 kb promoter region...
May 2, 2024: FEBS Letters
https://read.qxmd.com/read/38697899/disentangling-fetal-insulin-hypersecretion-and-insulin-resistance
#20
JOURNAL ARTICLE
Christopher J Nolan, Gernot Desoye
Disentangling which of insulin hypersecretion and insulin resistance is upstream in obesity-related type 2 diabetes (T2D) is challenging. Here, we consider the dynamics of insulin secretion and action in the fetuses of mothers with diabetes. We argue that fetal insulin hypersecretion occurs first, with insulin resistance being an adaptive protective response.
May 1, 2024: Trends in Endocrinology and Metabolism: TEM
keyword
keyword
110890
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.